Creative Medical TechnologyCELZ
Market Cap: 4.89M
About: Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Employees: 4
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
510% more capital invested
Capital invested by funds: $90.4K [Q4 2023] → $552K (+$461K) [Q1 2024]
300% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 0
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
63% more funds holding
Funds holding: 8 [Q4 2023] → 13 (+5) [Q1 2024]
6.38% more ownership
Funds ownership: 1.42% [Q4 2023] → 7.8% (+6.38%) [Q1 2024]
Research analyst outlook
We haven’t received any recent analyst ratings for CELZ.